Ajanta Pharma Limited
AJANTPHARM
Rang in Aktien
#3731
Established in 1973 and headquartered in Mumbai, India, Ajanta Pharma Limited... Established in 1973 and headquartered in Mumbai, India, Ajanta Pharma Limited operates as a specialized pharmaceutical enterprise. This company, along with its subsidiaries, is dedicated to the development, manufacturing, and commercialization of finished dosage forms. Its extensive product range caters to numerous therapeutic categories, such as anti-infectives (antibiotic, anti-malarial), chronic disease management (anti-diabetic, cardiology), women's health (gynecology), pediatrics, respiratory ailments, general health, dermatology, ophthalmology, and pain management. Notable products include multivitamins, antibiotics, eye drops, and cough syrups. Ajanta Pharma boasts a substantial international footprint, operating across India, Africa, other parts of Asia, the United States, and additional global markets. Furthermore, it supplies its pharmaceutical offerings to various government entities, including armed forces, public hospitals, and governmental procurement departments.
Aktienkurs
$35.98
Marktkapitalisierung
$4.50B
Veränderung (1 Tag)
-1.18%
Veränderung (1 Jahr)
29.38%
Land
IN
Handel Ajanta Pharma Limited (AJANTPHARM)
Kategorie
Healthcare
Umsatz von Ajanta Pharma Limited (AJANTPHARM)
Umsatz im Jun 2026 TTM: $637.45M
Laut den aktuellen Finanzberichten von Ajanta Pharma Limited beträgt der derzeitige Umsatz des Unternehmens (TTM) $637.45M. Im Jahr 2024 erzielte das Unternehmen einen Umsatz von $504.74M eine Steigerung gegenüber dem Umsatz im Jahr 2023, der $455.42M betrug. Der Umsatz ist der Gesamtbetrag, den ein Unternehmen durch den Verkauf von Waren oder Dienstleistungen erzielt. Im Gegensatz zum Gewinn werden keine Ausgaben abgezogen.
Umsatzverlauf für Ajanta Pharma Limited von 2005 bis 2026
Umsatz am Ende jedes Jahres
| Jahr | Umsatz | ändert |
|---|---|---|
| 2026 (TTM) | $637.45M | 17.29% |
| 2025 | $543.47M | 7.67% |
| 2024 | $504.74M | 10.83% |
| 2023 | $455.42M | 5.26% |
| 2022 | $432.64M | 11.24% |
| 2021 | $388.92M | 14.37% |
| 2020 | $340.05M | 17.10% |
| 2019 | $290.39M | -8.20% |
| 2018 | $316.32M | 7.04% |
| 2017 | $295.52M | 14.66% |
| 2016 | $257.74M | 10.53% |
| 2015 | $233.19M | 18.34% |
| 2014 | $197.05M | 16.14% |
| 2013 | $169.67M | 27.01% |
| 2012 | $133.59M | 17.92% |
| 2011 | $113.29M | 24.79% |
| 2010 | $90.78M | 31.92% |
| 2009 | $68.81M | -10.99% |
| 2008 | $77.31M | 29.89% |
| 2007 | $59.52M | 15.41% |
| 2006 | $51.57M | 13.41% |
| 2005 | $45.48M | 0.00% |
Umsatz vergleichbarer Unternehmen oder Wettbewerber
| Unternehmen | Umsatz | Umsatzunterschied | Land |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| $6.61B | 937.20% |
IN
|
